|
1
|
Torre LA, Bray F, Siegel RL, Ferlay J,
Lortet-Tieulent J and Jemal A: Global cancer statistics, 2012. CA
Cancer J Clin. 65:87–108. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Hensing T, Chawla A, Batra R and Salgia R:
A personalized treatment for lung cancer: Molecular pathways,
targeted therapies, and genomic characterization. Adv Exp Med Biol.
799:85–117. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Czarnecka-Kujawa K and Yasufuku K:
Molecular alterations in non-small-cell lung cancer: Perspective
for targeted therapy and specimen management for the
bronchoscopist. Respirology. 19:1117–1125. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Sarkar S, Roy BC, Hatano N, Aoyagi T,
Gohji K and Kiyama R: A novel ankyrin repeat-containing gene (Kank)
located at 9p24 is a growth suppressor of renal cell carcinoma. J
Biol Chem. 277:36585–36591. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Kakinuma N, Zhu Y, Wang Y, Roy BC and
Kiyama R: Kank proteins: Structure, functions and diseases. Cell
Mol Life Sci. 66:2651–2659. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Catic A, Kurtovic-Kozaric A, Johnson SH,
Vasmatzis G, Pins MR and Kogan J: A novel cytogenetic and molecular
characterization of renal metanephric adenoma: Identification of
partner genes involved in translocation t(9;15)(p24;q24). Cancer
Genet 214–215. 1–15. 2017.
|
|
7
|
Huang SF, Hsu HC and Fletcher JA:
Investigation of chromosomal aberrations in hepatocellular
carcinoma by fluorescence in situ hybridization. Cancer Genet
Cytogenet. 111:21–27. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Shao J, Li Y, Li H, Wu Q, Hou J and Liew
C: Deletion of chromosomes 9p and 17 associated with abnormal
expression of p53, p16/MTS1 and p15/MTS2 gene protein in
hepatocellular carcinomas. Chin Med J. 113:817–822. 2000.PubMed/NCBI
|
|
9
|
Sato M, Takahashi K, Nagayama K, Arai Y,
Ito N, Okada M, Minna JD, Yokota J and Kohno T: Identification of
chromosome arm 9p as themost frequent target of homozygous
deletions in lung cancer. Genes Chromosomes Cancer. 44:405–414.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Lo KC, Stein LC, Panzarella JA, Cowell JK
and Hawthorn L: Identification of genes involved in squamous cell
carcinoma of the lung using synchronized data from DNA copynumber
and transcript expression profiling analysis. Lung Cancer.
59:315–331. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Roy BC, Kakinuma N and Kiyama R: Kank
attenuates actin remodeling by preventing interaction between
IRSp53 and Rac1. J Cell Biol. 184:253–267. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Kralovics R, Teo SS, Buser AS, Brutsche M,
Tiedt R, Tichelli A, Passamonti F, Pietra D, Cazzola M and Skoda
RC: Altered gene expression in myeloproliferative disorders
correlates with activation of signaling by the V617F mutation of
Jak2. Blood. 106:3374–3376. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Clohisey SM, Dzhindzhev NS and Ohkura H:
Kank is an EB1 interacting protein that localises to muscle-tendon
attachment sites in Drosophila. PLoS One. 9:e1061122014. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Wang Y, Kakinuma N, Zhu Y and Kiyama R:
Nucleo-cytoplasmic shuttling of human Kank protein accompanies
intracellular translocation of beta-catenin. J Cell Sci.
119:4002–4010. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Roy BC, Aoyagi T, Sarkar S, Nomura K,
Kanda H, Iwaya K, Tachibana M and Kiyama R: Pathological
characterization of Kank in renal cell carcinoma. Exp Mol Pathol.
78:41–48. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Ghavami S, Hashemi M, Ande SR, Yeganeh B,
Xiao W, Eshraghi M, Bus CJ, Kadkhoda K, Wiechec E, Halayko AJ, et
al: Apoptosis and cancer: Mutations within caspase genes. J Med
Genet. 46:497–510. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Ghasemian M, Mahdavi M, Zare P and Ali
Hosseinpour Feizi M: Spiroquinazolinone-induced cytotoxicity and
apoptosis in K562 human leukemia cells: Alteration in expression
levels of Bcl-2 and Bax. J Toxicol Sci. 40:115–126. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Sela B: Survivin: Anti-apoptosis protein
and a prognostic marker for tumor progression and recurrence.
Harefuah. 141:103–107. 1232002.(In Hebrew). PubMed/NCBI
|
|
19
|
Jia J, Furlan A, Gonzalez-Hilarion S,
Leroy C, Gruenert DC, Tulasne D and Lejeune F: Caspases shutdown
nonsense-mediated mRNA decay during apoptosis. Cell Death Differ.
22:1754–1763. 2015. View Article : Google Scholar : PubMed/NCBI
|
